K C Cundy

2.4k total citations · 1 hit paper
21 papers, 2.0k citations indexed

About

K C Cundy is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, K C Cundy has authored 21 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 8 papers in Epidemiology and 5 papers in Molecular Biology. Recurrent topics in K C Cundy's work include HIV/AIDS drug development and treatment (9 papers), Polyomavirus and related diseases (5 papers) and HIV Research and Treatment (4 papers). K C Cundy is often cited by papers focused on HIV/AIDS drug development and treatment (9 papers), Polyomavirus and related diseases (5 papers) and HIV Research and Treatment (4 papers). K C Cundy collaborates with scholars based in United States and France. K C Cundy's co-authors include R. Kohen, B N Ames, Yumi Yamamoto, Peter A. Crooks, Howard S. Jaffe, Pearl Fisher, J P Shaw, B N Ames, Jung‐Won Park and Michael J. M. Hitchcock and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

K C Cundy

21 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Antioxidant activity of carnosine, homocarnosine, and anserine present in muscle and brain.

1988 677 citations R. Kohen, Yumi Yamamoto et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
K C Cundy United States	18	598	584	501	474	434	21	2.0k
Leonarda Troiano Italy	35	348 0.6×	315 0.5×	121 0.2×	301 0.6×	1.5k 3.4×	72	3.3k
Edward P. Garvey United States	39	1.3k 2.2×	1.3k 2.3×	727 1.5×	1.9k 4.1×	1.5k 3.5×	82	5.1k
Mark Laughlin United States	18	303 0.5×	934 1.6×	128 0.3×	1.2k 2.6×	447 1.0×	33	2.4k
Peter T. Meinke United States	33	341 0.6×	319 0.5×	904 1.8×	261 0.6×	2.2k 5.2×	108	4.2k
Ping Lü China	28	307 0.5×	298 0.5×	106 0.2×	451 1.0×	1.1k 2.5×	69	2.6k
Yazen Alnouti United States	33	196 0.3×	612 1.0×	125 0.2×	608 1.3×	1.0k 2.4×	91	3.5k
Michael A. Chirigos United States	28	140 0.2×	230 0.4×	408 0.8×	235 0.5×	785 1.8×	111	2.8k
C. V. Ramakrishnan India	25	185 0.3×	512 0.9×	109 0.2×	629 1.3×	743 1.7×	156	2.3k
Alain Pruvost France	30	152 0.3×	323 0.6×	73 0.1×	885 1.9×	671 1.5×	80	2.2k
Larry M. Gordon United States	30	239 0.4×	171 0.3×	96 0.2×	213 0.4×	1.6k 3.6×	64	2.7k

Countries citing papers authored by K C Cundy

Since Specialization

Citations

This map shows the geographic impact of K C Cundy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K C Cundy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K C Cundy more than expected).

Fields of papers citing papers by K C Cundy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K C Cundy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K C Cundy. The network helps show where K C Cundy may publish in the future.

Co-authorship network of co-authors of K C Cundy

This figure shows the co-authorship network connecting the top 25 collaborators of K C Cundy. A scholar is included among the top collaborators of K C Cundy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K C Cundy. K C Cundy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Monte, Andrew A., et al.. (2023). 304 Randomized Controlled Trial of ANEB-001 as an Antidote for Acute Cannabinoid Intoxication in Healthy Adults. Annals of Emergency Medicine. 82(4). S133–S133. 1 indexed citations

Vakil, Nimish, F. Jacob Huff, & K C Cundy. (2013). Randomised clinical trial: arbaclofen placarbil in gastro‐oesophageal reflux disease – insights into study design for transient lower sphincter relaxation inhibitors. Alimentary Pharmacology & Therapeutics. 38(2). 107–117. 20 indexed citations

Lal, Rattan, Juthamas Sukbuntherng, Jcm Ho, & K C Cundy. (2011). A phase I, single-dose study of the disposition of 14C-radiolabeled gabapentin enacarbil in healthy male volunteers. International Journal of Clinical Pharmacology and Therapeutics. 49(2). 109–115. 5 indexed citations

Lal, Rattan, et al.. (2010). The effect of food with varying fat content on the clinical pharmacokinetics of gabapentin after oral administration of gabapentin enacarbil. International Journal of Clinical Pharmacology and Therapeutics. 48(2). 120–128. 17 indexed citations

Barditch‐Crovo, Patricia, et al.. (1997). Anti‐Human Immunodeficiency Virus (HIV) Activity, Safety, and Pharmacokinetics of Adefovir Dipivoxil (9‐[2‐(bis‐pivaloyloxymethyl)‐phosphonylmethoxyethyl]adenine) in HIV‐Infected Patients. The Journal of Infectious Diseases. 176(2). 406–413. 86 indexed citations

Louie, Michael S., V. V. Krishnamurthy, Murty N. Arimilli, et al.. (1997). Pharmacokinetics and metabolism of selected prodrugs of PMEA in rats.. PubMed. 25(3). 362–6. 49 indexed citations

Dougherty, Joseph P., Andrew Mulato, Reza Oliyai, et al.. (1997). Synthesis, in Vitro Biological Evaluation and Oral Bioavailability of 9-[2-(Phosphonomethoxy)Propyl]Adenine (PMPA) Prodrugs. Antiviral chemistry & chemotherapy. 8(6). 557–564. 95 indexed citations

Eisenberg, Eugene, et al.. (1997). Penetration of GS4071, a novel influenza neuraminidase inhibitor, into rat bronchoalveolar lining fluid following oral administration of the prodrug GS4104. Antimicrobial Agents and Chemotherapy. 41(9). 1949–1952. 67 indexed citations

Cundy, K C, et al.. (1996). Pharmacokinetics, bioavailability, metabolism, and tissue distribution of cidofovir (HPMPC) and cyclic HPMPC in rats.. Drug Metabolism and Disposition. 24(7). 745–752. 58 indexed citations

10.

Cundy, K C, et al.. (1996). Effect of probenecid on the distribution, metabolism, and excretion of cidofovir in rabbits.. Drug Metabolism and Disposition. 24(3). 315–321. 34 indexed citations

11.

Cundy, K C, et al.. (1996). Pharmacokinetics of cidofovir in monkeys. Evidence for a prolonged elimination phase representing phosphorylated drug.. Drug Metabolism and Disposition. 24(7). 738–744. 37 indexed citations

12.

Wachsman, M., Brent G. Petty, K C Cundy, et al.. (1996). Pharmacokinetics, safety and bioavailability of HPMPC (cidofovir) in human immunodeficiency virus-infected subjects. Antiviral Research. 29(2-3). 153–161. 73 indexed citations

13.

Lalezari, Jacob, William Drew, Christopher W. James, et al.. (1995). (S)-1-[3-Hydroxy-2-(Phosphonylmethoxy)propyl]cytosine (Cidofovir): Results of a Phase I/II Study of a Novel Antiviral Nucleotide Analogue. The Journal of Infectious Diseases. 171(4). 788–796. 152 indexed citations

14.

Cundy, K C, Patricia Barditch‐Crovo, Robert Walker, et al.. (1995). Clinical pharmacokinetics of adefovir in human immunodeficiency virus type 1-infected patients. Antimicrobial Agents and Chemotherapy. 39(11). 2401–2405. 109 indexed citations

15.

Cundy, K C, Brent G. Petty, John F. Flaherty, et al.. (1995). Clinical pharmacokinetics of cidofovir in human immunodeficiency virus-infected patients. Antimicrobial Agents and Chemotherapy. 39(6). 1247–1252. 141 indexed citations

16.

Cundy, K C, et al.. (1994). Oral, subcutaneous, and intramuscular bioavailabilities of the antiviral nucleotide analog 9-(2-phosphonylmethoxyethyl) adenine in cynomolgus monkeys. Antimicrobial Agents and Chemotherapy. 38(2). 365–368. 34 indexed citations

17.

Park, Jung‐Won, K C Cundy, & B N Ames. (1989). Detection of DNA adducts by high-performance liquid chromatography with electrochemical detection. Carcinogenesis. 10(5). 827–832. 95 indexed citations

18.

Kohen, R., Yumi Yamamoto, K C Cundy, & B N Ames. (1988). Antioxidant activity of carnosine, homocarnosine, and anserine present in muscle and brain.. Proceedings of the National Academy of Sciences. 85(9). 3175–3179. 677 indexed citations breakdown →

19.

Cundy, K C & Peter A. Crooks. (1984). High-performance liquid chromatographic method for the determination of N-methylated metabolites of nicotine. Journal of Chromatography B Biomedical Sciences and Applications. 306. 291–301. 38 indexed citations

20.

Cundy, K C & Peter A. Crooks. (1983). Unexpected pehnomenon in the high-performance liquid chromatographic anlaysis of racemic 14C-labelled nicotine: Separation of enantiomers in a totally achiral system. Journal of Chromatography A. 281. 17–33. 106 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact